LU Xiaojie,ZHAO Yuetong,WU Shuang,et al.Research progress on regulation of intestinal microbiota by traditional Chinese medicine in intervention of hyperuricemia[J].Shanghai Journal of Traditional Chinese Medicine,2025,59(12):103-110.
LU Xiaojie,ZHAO Yuetong,WU Shuang,et al.Research progress on regulation of intestinal microbiota by traditional Chinese medicine in intervention of hyperuricemia[J].Shanghai Journal of Traditional Chinese Medicine,2025,59(12):103-110. DOI: 10.16305/j.1007-1334.2025.z20250114003.
Research progress on regulation of intestinal microbiota by traditional Chinese medicine in intervention of hyperuricemia
Hyperuricemia (HUA) is a metabolic disease. According to traditional Chinese medicine (TCM) theory, its pathogenesis is closely linked to dysfunction of the liver, spleen, and kidneys, as well as an imbalance in the intestinal microbiota. The intestinal microbiota influence uric acid metabolism via multiple pathways. Based on this understanding, TCM utilizes various approaches to modulate the intestinal microbiota to treat HUA. These methods are characterized by their safety and efficacy, offering novel insights into preventing and treating HUA. Nevertheless, further investigation is warranted regarding issues such as clinical translation, personalized treatment strategies, and long-term safety. This article reviews the research progress of TCM regulating intestinal microflora to intervene HUA, in order to provide reference for the application of TCM in the prevention and treatment of HUA.
MALOBERTI A , QUALLIU E , OCCHI L , et al . Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage [J]. Nutr Metab Cardiovasc Dis , 2021 , 31 ( 1 ): 178 - 185 .
ZHANG M , ZHU X , WU J , et al . Prevalence of hyperuricemia among Chinese adults: findings from two nationally representative cross-sectional surveys in 2015-16 and 2018-19 [J]. Front Immunol , 2022 , 12 : 791983 .
TERKELTAUB R , DODD D . The gut microbiome in hyperuricemia and gout [J]. Arthritis Rheumatol , 2025 , 77 ( 8 ): 955 - 965 .
MARTINEZ-NAVA G A , MENDEZ-SALAZAR E O , VAZQUEZ-MELLADO J , et al . Metatranscriptomic analysis reveals gut microbiome bacterial genes in pyruvate and amino acid metabolism associated with hyperuricemia and gout in humans [J]. Sci Rep , 2025 , 15 ( 1 ): 9981 .
BUTLER F , ALGHUBAYSHI A , ROMAN Y . The epidemiology and genetics of hyperuricemia and gout across major racial groups: A literature review and population genetics secondary database analysis [J]. J Pers Med , 2021 , 11 ( 3 ): 231 .
MARTINEZ-NAVA G A , MENDEZ-SALAZAR E O , VAZQUEZ-MELLADO J , et al . The impact of short-chain fatty acid-producing bacteria of the gut microbiota in hyperuricemia and gout diagnosis [J]. Clin Rheumatol , 2023 , 42 ( 1 ): 203 - 214 .
MENDEZ-SALAZAR E O , VAZQUEZ-MELLADO J , CASIMIRO-SORIGUER C S , et al . Taxonomic variations in the gut microbiome of gout patients with and without tophi might have a functional impact on urate metabolism [J]. Mol Med , 2021 , 27 ( 1 ): 50 .
LIU Y , JARMAN J B , LOW Y S , et al . A widely distributed gene cluster compensates for uricase loss in hominids [J]. Cell , 2023 , 186 ( 16 ): 3400 - 3413 .
CICERO A F G , FOGACCI F , KUWABARA M , et al . Therapeutic strategies for the treatment of chronic hyperuricemia: an evidence-based update [J]. Medicina (Kaunas) , 2021 , 57 ( 1 ): 58 .
WANG Y B , JIN C Z . Roles of traditional Chinese medicine extracts in hyperuricemia and gout treatment: Mechanisms and clinical applications [J]. World J Gastroenterol , 2024 , 30 ( 47 ): 5076 - 5080 .
CHENG S , SUN H , LI X , et al . Effects of alismatis rhizoma and rhizoma smilacis glabrae decoction on hyperuricemia in rats [J]. Evid Based Complement Alternat Med , 2019 : 4541609 .
LI Y , WU T , LI H , et al . Tanshinone ⅡA promoted autophagy and inhibited inflammation to alleviate podocyte injury in diabetic nephropathy [J]. Diabetes Metab Syndr Obes , 2024 , 17 : 2709 - 2724 .
LI Y J , CHEN L R , YANG Z L , et al . Comparative efficacy and safety of uricosuric agents in the treatment of gout or hyperuricemia: a systematic review and network meta-analysis [J]. Clin Rheumatol , 2023 , 42 ( 1 ): 215 - 224 .
CANI P D , AMAR J , IGLESIAS M A , et al . Metabolic endotoxemia initiates obesity and insulin resistance [J]. Diabetes , 2007 , 56 ( 7 ): 1761 - 1772 .
ZHANG Z , CAO H , SHEN P , et al . Ping weisan alleviates chronic colitis in mice by regulating intestinal microbiota composition [J]. J Ethnopharmacol , 2020 , 255 : 112715 .
WANG J , CHEN Y , ZHONG H , et al . The gut microbiota as a target to control hyperuricemia pathogenesis: potential mechanisms and therapeutic strategies [J]. Crit Rev Food Sci Nutr , 2022 , 62 ( 14 ): 3979 - 3989 .
MASEDA D , RICCIOTTI E . NSAID-gut microbiota interactions [J]. Front Pharmacol , 2020 , 11 : 1153 .
FAN M D , LIU J , ZHAO B C , et al . Comparison of efficacy and safety of urate-lowering therapies for hyperuricemic patients with gout: a meta-analysis of randomized, controlled trials [J]. Clin Rheumatol , 2021 , 40 ( 2 ): 683 - 692 .
LIN T L , LU C C , LAI W F , et al . Role of gut microbiota in identification of novel TCM-derived active metabolites [J]. Protein Cell , 2021 , 12 ( 5 ): 394 - 410 .
YANAI H , ADACHI H , HAKOSHIMA M , et al . Molecular biological and clinical understanding of the pathophysiology and treatments of Hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease [J]. Int J Mol Sci , 2021 , 22 ( 17 ): 9221 .
LYU Q , ZHOU J , WANG C , et al . Corrigendum: A dynamics association study of gut barrier and microbiota in hyperuricemia [J]. Front Microbiol , 2024 , 15 : 1358594 .
WEI J , ZHANG Y , DALBETH N , et al . Association between gut microbiota and elevated serum urate in two independent cohorts [J]. Arthritis Rheumatol , 2022 , 74 ( 4 ): 682 - 691 .
YU L L , LI C N , FANG M Y , et al . Evaluating the effectiveness and safety of acupuncture on serum uric acid in asymptomatic hyperuricemia population: a randomized controlled clinical trial study protocol [J]. Front Endocrinol (Lausanne) , 2023 , 14 : 1218546 .
YU Z , LIU R , SU K , et al . Acupuncture ameliorates breast cancer-related fatigue by regulating the gut microbiota-gut-brain axis [J]. Front Endocrinol (Lausanne) , 2022 , 13 : 921119 .
Exploring feasibility of strengthening spleen and nourishing kidney method in regulating intestinal microflora in treatment of systemic lupus erythematosus based on "kidney‑spleen‑intestine axis" theory
Preliminary study on pathogenesis of phlegm⁃stasis⁃toxin intermingling in stroke
Exploration of five antiemetic methods for treating vomiting in diabetic nephropathy
Tang Qiang's experience in treating post‑stroke depression with "nourishing spirit and unblocking fu‑organs" acupuncture method
Discussing treatment ideas of cancer⁃caused fatigue based on theory of "treating deficiency with three principles and two unities"
Related Author
QIAN Ai
HUANG Chuanbing
ZHU Yawen
CHENG Yuanyuan
HU Kexin
ZHANG Yunfan
ZHAO Di
MIAO Lina
Related Institution
The First Affiliated Hospital of Anhui University of Chinese Medicine, Center for Xin'an Medicine and Moderization of Traditional Chinese Medicine
Graduate School, Beijing University of Chinese Medicine
Department of Encephalopathy, Xiyuan Hospital, China Academy of Chinese Medical Sciences
Department of Traditional Chinese Medicine, Shenzhen People's Hospital
Department of Endocrinology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine